4-hydroxycinnamoyl(feroyl)methane, curcumin II, demethoxy-curcumin, demethoxycurcumin, monodemethoxycurcumin

| Name | Demethoxycurcumin | ||
| PubChem CID | 5469424 | ||
| Molecular Weight | 338.4g/mol | ||
| Synonyms |
4-hydroxycinnamoyl(feroyl)methane, curcumin II, demethoxy-curcumin, demethoxycurcumin, monodemethoxycurcumin |
||
| Formula | C₂₀H₁₈O₅ | ||
| SMILES | COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O | ||
| InChI | 1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+ | ||
| InChIKey | HJTVQHVGMGKONQ-LUZURFALSA-N | ||
| CAS Number | 22608-11-3 | ||
| ChEMBL ID | CHEMBL105360 | ||
| ChEBI ID | CHEBI:65737 | ||
| Herb ID | HBIN023227 | ||
| Structure |
Download
2D
MOL
3D
MOL
|
||
| Chineses Pinyin | BiBa | ||
| Use Part | Near Ripe Or Ripe Fruit Spike | ||
| Habitat | YunNan, GuangDong | ||
| Flavor | Pungent | ||
| Meridian Tropism | Stomach, Large intestine | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Piperales
-->Family: Piperaceae
-->Genus: Piper
-->Species: Piper longum
|
||
| Chineses Pinyin | JiangHuang | ||
| Use Part | Tuberoid | ||
| Habitat | SiChuan, FuJian, GuangDong, ZheJiang, JiangXi | ||
| Flavor | Pungent; Bitter | ||
| Meridian Tropism | Spleen; Liver | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Zingiberales
-->Family: Zingiberaceae
-->Genus: Curcuma
-->Species: Curcuma longa
|
||
| Pair Name | Demethoxycurcumin, Cisplatin | |||
| Partner Name | Cisplatin | |||
| Disease Info | [ICD-11: 2C25.Z] | Lung cancer | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
| In Vivo Model | For a xenograft model, A549/DDP cells were injected into the inguinal mammary fat pad of Balb/c congenic athymic nude mice. | |||
| Result | The findings from the present study suggested that DMC in combination with DDP may be considered as a novel combination regimen for restoring DDP sensitivity in DDP-resistant NSCLC cells. | |||
| Pair Name | Demethoxycurcumin, AT101 | |||
| Partner Name | AT101 | |||
| Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
| Gene Regulation | Up-regulation | Phosphorylation | AKT1 | hsa207 |
| In Vitro Model | PC-1 [Human pancreatic carcinoma] | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_S969 |
| PC-2 [Human pancreatic carcinoma Germany] | Pancreatic carcinoma | Homo sapiens (Human) | CVCL_C1YF | |
| PC-3 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0035 | |
| Result | Combined treatment with different drugs might be an option to efficiently overcome chemoresistance of GBM cells in a long-term treatment strategy. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway. Oncol Lett. 2020 Nov;20(5):209. doi: 10.3892/ol.2020.12072. | Click |
| 2 | Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol. 2020 Jan;146(1):117-126. doi: 10.1007/s00432-019-03107-7. | Click |